ACVAX Performance — Strategic Allocation: Aggressive Fund, A Class
Data updated: 2026-10-14
ACVAX returned +7.40% year to date and +14.25% over one year to Jul 2026. Annualised returns are +12.94% over 3 years and +6.84% over 5 years. Against its US Multi-Cap Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $144, against $139 for the category, and to $114 over one year, against $114. Volatility over the past three years was 10.58% a year. In the 12 months to Jul 2026 the fund lost a net $10.2M, and assets reached $735.10M.
ACVAX Growth of $100
What $100 invested in Strategic Allocation: Aggressive Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Blend category average over the same months.
| Period | ACVAX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $114 |
| 3 years (Aug 2023 – Jul 2026) | $144 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $139 | $135 |
| Since data start (Aug 2019 – Jul 2026) | $196 | $172 |
ACVAX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.40% |
| 1 year | +14.25% |
| 3 years (annualised) | +12.94% |
| 5 years (annualised) | +6.84% |
ACVAX Annual Returns
Calendar-year total returns of Strategic Allocation: Aggressive Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.40% |
| 2025 | +15.43% |
| 2024 | +12.74% |
| 2023 | +15.07% |
| 2022 | −15.67% |
| 2021 | +14.75% |
| 2020 | +18.02% |
| 2019 (Aug–Dec) | +6.70% |
ACVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.8% | +1.9% | −5.8% | +6.3% | +2.8% | +0.2% | −0.5% | — | — | — | — | — |
| 2025 | +3.1% | −1.0% | −2.8% | +0.4% | +4.5% | +3.5% | +0.7% | +2.7% | +1.6% | +0.8% | +0.7% | +0.6% |
| 2024 | 0.0% | +3.3% | +2.9% | −3.7% | +3.4% | +0.8% | +2.5% | +2.2% | +1.8% | −2.0% | +4.9% | −3.5% |
| 2023 | +6.4% | −2.5% | +1.6% | +0.4% | −1.8% | +4.7% | +2.6% | −2.4% | −3.7% | −3.0% | +7.5% | +5.2% |
| 2022 | −4.9% | −1.9% | +0.8% | −6.4% | +0.3% | −7.3% | +6.4% | −3.3% | −8.1% | +5.7% | +6.9% | −3.6% |
| 2021 | −0.2% | +2.8% | +2.1% | +3.6% | +0.7% | +1.2% | +1.1% | +1.9% | −3.5% | +4.1% | −2.6% | +3.0% |
| 2020 | −0.7% | −5.7% | −13.0% | +10.1% | +5.7% | +2.1% | +5.0% | +4.5% | −1.9% | −1.4% | +10.3% | +4.1% |
| 2019 | — | — | — | — | — | — | — | −1.3% | +1.4% | +1.6% | +2.5% | +2.3% |
ACVAX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 10.58%
- 3-year Sharpe ratio: 0.80 (vs 4.5% risk-free rate)
- Best month: +7.48% (Nov 2023)
- Worst month: −5.85% (Mar 2026)
ACVAX Fund Flows
Monthly money in and out of Strategic Allocation: Aggressive Fund, from SEC Form N-PORT.
- 12-month net flow: −$10.2M
- 12-month gross sales (incl. reinvestments): $139.9M
- Sales ÷ redemptions: 0.93×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $6.8M | $17.2M | −$10.4M |
| Jun 2026 | $5.1M | $10.7M | −$5.6M |
| May 2026 | $7.5M | $10.7M | −$3.2M |
| Apr 2026 | $7.2M | $10.3M | −$3.1M |
| Mar 2026 | $7.4M | $19.4M | −$12.0M |
| Feb 2026 | $13.8M | $10.2M | $3.6M |
| Jan 2026 | $6.6M | $14.7M | −$8.1M |
| Dec 2025 | $57.8M | $13.7M | $44.1M |
| Nov 2025 | $5.6M | $10.2M | −$4.7M |
| Oct 2025 | $6.6M | $11.5M | −$4.9M |
| Sep 2025 | $10.0M | $13.2M | −$3.2M |
| Aug 2025 | $5.5M | $8.3M | −$2.7M |
ACVAX Assets Under Management
Net assets of Strategic Allocation: Aggressive Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $735.10M |
| 2026-04-30 | $735.62M |
| 2026-01-31 | $733.12M |
| 2025-10-31 | $719.94M |
| 2025-07-31 | $694.96M |
| 2025-04-30 | $645.21M |
| 2025-01-31 | $681.92M |
| 2024-10-31 | $665.71M |
| 2024-07-31 | $663.01M |
| 2024-04-30 | $631.91M |
| 2024-01-31 | $652.86M |
| 2023-10-31 | $598.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.